{
  "app": {
    "title": "SK Chemicals Open Innovation"
  },

  "nav": {
    "title": "Open Innovation",
    "sub_title": "SK Chemicals Open Innovation",
    "introduction": {
      "title": "Introduction",
      "sub_title": "R&D capabilities being on par with global standards"
    } ,
    "timeline": {
      "title": "Timeline",
      "sub_title": "R&D capabilities being on par with global standards"
    } ,
    "members": {
      "title": "Members",
      "sub_title": "R&D capabilities being on par with global standards"
    } ,
    "pharma": {
      "title": "Pharma",
      "sub_title": "R&D capabilities being on par with global standards"
    } ,
    "research":{
      "title": "Research",
      "sub_title": "R&D capabilities being on par with global standards"
    } ,
    "investments": {
      "title": "Investments",
      "sub_title": "R&D capabilities being on par with global standards"
    },
    "contactUs": {
      "title": "Contact Us",
      "sub_title": "R&D capabilities being on par with global standards"
    },
    "partnerships": {
      "title": "Partnerships",
      "sub_title": "R&D capabilities being on par with global standards"
    }
  },

  "footer": {
    "text": "310 Pangyo-ro, Bundang-gu, Seongnam-si, Gyeonggi-do <br/> 463-400 Korea [13494]<br />Copyright(c) SK chemicals. All Rights Reserved."
  },

  "home": {
    "slide": {
      "1": {
        "title": "SK Chemicals <br /> <span class='sub_heading'>Open Innovation Team</span>",
        "description": "We promote the health of humankind and <span>protect the environment of the Earth</span>"
      },
      "2": {
        "title": "<span class='sub_heading'>This is an</span> <br /> Irrelevant Image",
        "description": "We promote the health of humankind and <span>protect the environment of the Earth</span>"
      },
      "3": {
        "title": "<span class='sub_heading'>Focusing on</span> <br /> Research & Development",
        "description": "We promote the health of humankind and <span>protect the environment of the Earth</span>"
      },
      "4": {
        "title": "COVID 19 <br /> <span class='sub_heading'>vaccine development</span>",
        "description": "We promote the health of humankind and <span>protect the environment of the Earth</span>"
      }
    }
  },

  "intro": {
    "p_title": "SK Chemicals always looks <br class='pc_only'/> for ways to make better pharmaceutical products",
    "text_board": {
      "1": {
        "title": "Overview",
        "description": "R&D is the source of competitiveness for pharmaceutical companies. As such, SK Chemicals has committed its research capabilities in developing pharmaceutical products with global competitiveness. SK Chemicals Research Center holds outstanding competencies and expertise across all stages of pharmaceutical R&D including drug formulations research, analytical research, process development and manufacturing of various dosage forms."
      },
      "2": {
        "title": "Quality by Design",
        "description": "R&D is the source of competitiveness for pharmaceutical companies. As such, SK Chemicals has committed its research capabilities in developing pharmaceutical products with global competitiveness. SK Chemicals Central Research Center holds outstanding competencies and expertise across all stages of pharmaceutical R&D including drug formulations research, analytical research, process development and manufacturing of various dosage forms."
      },
      "3": {
        "title": "Key Areas",
        "description": "R&D is the source of competitiveness for pharmaceutical companies. As such, SK Chemicals has committed its research capabilities in developing pharmaceutical products with global competitiveness. SK Chemicals Central Research Center holds outstanding competencies and expertise across all stages of pharmaceutical R&D including drug formulations research, analytical research, process development and manufacturing of various dosage forms."
      }
    }
  },

  "timeline": {
    "p_title": "SK Chemicals always looks <br class='pc_only'/> for ways to make better pharmaceutical products",
    "text_board": {
      "1": {
        "title": "Overview",
        "description": "R&D is the source of competitiveness for pharmaceutical companies. As such, SK Chemicals has committed its research capabilities in developing pharmaceutical products with global competitiveness. SK Chemicals Research Center holds outstanding competencies and expertise across all stages of pharmaceutical R&D including drug formulations research, analytical research, process development and manufacturing of various dosage forms."
      }
    },
    "diagram": [
      {
        "color": "cyan",
        "year": "2017",
        "title": "Pilot Project",
        "description": ["1. Drug repositioning (DR)*", "2. 이대 김완규 Professor"]
      },
      {
        "color": "green",
        "year": "2019",
        "title": "Open Innovation",
        "description": [
          "1. Open R&D TF launched",
          "2. Selected 3 key diseases",
          "3. Promotion of external cooperation"
        ]
      },
      {
        "color": "pink",
        "year": "2020",
        "title": "R&D development of new drugs and expansion of cooperation",
        "description": ["1. DR patent application (2 cases)", "2. Expanding networks on AI partner organizations"]
      },
      {
        "color": "amber",
        "year": "2021",
        "title": "Strengthening capabilities and introducing formal tasks",
        "description": ["1. Build of internal AI model"]
      },
      {
        "color": "orange",
        "year": "2022",
        "title": "Advanced assignments",
        "description": ["1. Secured the pipeline for new drugs", "2. Early Stage L/O"]
      }
    ]
  },

  "members": {
    "p_title": "SK Chemicals always looks <br class='pc_only'/> for ways to make better pharmaceutical products",
    "member_list": {
      "executives": [
        {
          "name": "Soomin Lee",
          "role": "Open Innovation Team Leader",
          "description": "Lorem ipsum dolor sit amet, no nam oblique veritus. Communescaevola imperdiet nec ut, sed euismod convenire principes at.",
          "style": "margin-left: auto;",
          "image": "https://source.unsplash.com/c_GmwfHBDzk/",
          "email": "mrlee@example.com"
        }
      ],
      "managers": [
        {
          "name": "Jiho Heo",
          "role": "Pharma Planning Team Leader",
          "description": "Lorem ipsum dolor sit amet, no nam oblique veritus. Communescaevola imperdiet nec ut, sed euismod convenire principes at.",
          "style": "margin-right: auto;",
          "email": "teammember_허지호@example.com"
        },
        {
          "name": "Kwonhee Choi",
          "role": "Open Innovation team manager",
          "description": "Lorem ipsum dolor sit amet, no nam oblique veritus. Communescaevola imperdiet nec ut, sed euismod convenire principes at.",
          "style": "margin-right: auto;",
          "email": "teammember_촤권희@example.com"
        },
        {
          "name": "Jongin Kim",
          "role": "Open Innovation team manager",
          "description": "Lorem ipsum dolor sit amet, no nam oblique veritus. Communescaevola imperdiet nec ut, sed euismod convenire principes at.",
          "style": "margin-left: auto;",
          "image": "",
          "email": "teammember_김종인@example.com"
        },
        {
          "name": "Yuldam Kim",
          "role": "Open Innovation team manager",
          "description": "Lorem ipsum dolor sit amet, no nam oblique veritus. Communescaevola imperdiet nec ut, sed euismod convenire principes at.",
          "style": "margin-right: auto;",
          "image": "",
          "email": "teammember_김율담@example.com"
        },
        {
          "name": "SeungJu Yeon",
          "role": "Open Innovation team manager",
          "description": "Lorem ipsum dolor sit amet, no nam oblique veritus. Communescaevola imperdiet nec ut, sed euismod convenire principes at.",
          "style": "margin-left: auto;",
          "image": "",
          "email": "teammember_연승주@example.com"
        },
        {
          "name": "Namgin Koo",
          "role": "Open Innovation team manager",
          "description": "Lorem ipsum dolor sit amet, no nam oblique veritus. Communescaevola imperdiet nec ut, sed euismod convenire principes at.",
          "style": "margin-right: auto;",
          "image": "",
          "email": "teammember_구남진@example.com"
        },
        {
          "name": "Jihyeon Park",
          "role": "Open Innovation team manager",
          "description": "Lorem ipsum dolor sit amet, no nam oblique veritus. Communescaevola imperdiet nec ut, sed euismod convenire principes at.",
          "style": "margin-left: auto;",
          "image": "",
          "email": "teammember_박지현@example.com"
        },
        {
          "name": "Donghyuk Kim",
          "role": "Open Innovation team manager",
          "description": "Lorem ipsum dolor sit amet, no nam oblique veritus. Communescaevola imperdiet nec ut, sed euismod convenire principes at.",
          "style": "margin-right: auto;",
          "image": "",
          "email": "teammember_김동혁@example.com"
        }
      ]
    }
  },

  "pharma": {
    "p_title": "SK Chemicals는 더 나은 신약을 만들기 위해 <br class='pc_only' /> 끊임없이 고민하고 연구합니다",
    "text_board": {
      "aim": {
        "title": "Goal",
        "description": [
          "Based on experts in each field, we aim to lead the success of developing new drugs and develops new global drugs to promote human health.",
          "Through open innovation, joint research with promising ventures will be conducted, and based on this, the development of new drugs will lead to success."
        ]
      },
      "fields": {
        "title": "Fields of research",
        "description": "The Open Innovation team selected <span class='ff_m'>NASH</span> (non-alcoholic steatohepatitis) and <span class='ff_m'>IPF</span> (Idiopathic pulmonary fibrosis) as key disease areas, focusing on discovery of First-in-Class drugs. Meanwhile, we are expanding our disease area to other indications that require strategic technological innovation in addition to the two diseases."
      }
    }
  },

  "research": {
    "p_title": "SK Chemicals 오픈이노베이션 팀은 <br class='pc_only' /> 끊임없이 고민하고 연구합니다",
    "text_board": {
      "aim": {
        "title": "연구 목표",
        "description": "효과적인 치료법이 없는 적응증을 중심으로 오픈 이노베이션을 통해 보다 효율적인 신약개발 연구에 초점을 두고 있습니다."
      },
      "strategy": {
        "title": "연구 전략",
        "description": "오픈 이노베이션을 통한 다양한 파트너사와의 공동연구를 바탕으로 인공지능(<span class= 'ff_m'>AI</span>) 신약 및 표적단백질 분해 (<span class= 'ff_m'>Targeted Protein Degradation</span>) 등의 차세대 기술을 이용하여 혁신적인 신약개발의 성공 가능성을 극대화하고 있습니다."
      },
      "capacity": {
        "title": "연구 역량",
        "description": [
          "연구 전문 인력을 중심으로 중점 질환을 극복할 수 있는 신규 타깃 발굴을 수행하고 있으며, 약효, 합성, 독성 및 <span class= 'ff_m'>PK</span> 전문인력들이 후보물질 도출과 검증을 진행하고 있습니다.",
          "임상, 허가, 약가, 생산 및 마케팅 등 전문 부서와 협업하여 신약개발의 전 단계를 수행할 수 있는 역량을 보유하고 있습니다."
        ]
      }
    }
  },

  "investments": {
    "p_title": "SK Chemicals pursues <br class='pc_only'/> shared growth with the venture industry",
    "text_board": {
      "overview": {
        "title": "Overview",
        "description": "The future of the pharmaceutical industry depends on cooperation, hence innovation requires investment. In order to solve the new problem of healthcare thrown by the rapidly changing era, <span class='ff_m'>SK</span> Chemicals actively supports promising bio-ventures at home and abroad."
      },
      "aim": {
        "title": "Aim",
        "description": "SK Chemicals wants to cooperate as a strategic investor with bio venture companies with excellent R&D capabilities and technology. We are looking for a venture company that will share the fruits of its performance by jointly striving for the successful development and commercialization of technology and corporate growth."
      },
      "fields": {
        "title": "Fields of research",
        "description": "In addition to the key areas where SK Chemicals can fully utilize its experiences and capabilities, we are also actively considering future technology areas that will drive trends in the pharmaceutical industry.",
        "strategic": {
          "title": "Strategic focus areas",
          "list": [
            "Promising technologies that can be applied to NASH (non-alcoholic steatohepatitis), fibrosis disease, and rheumatoid arthritis, which are internal R&D focus areas.",
            "New drug candidates in areas where SK Chemicals has an understanding of the market and diseases, such as nervous system, musculoskeletal system, and urinary system diseases, etc."
          ]
        },
        "future": {
          "title": "Future leading edge technology areas",
          "list": [
            "Future technologies that present new paradigms such as targeted protein decomposition, gene therapy, and cell therapy.",
            "New drug candidates that have potential for diseases with high medical unmet demand, such as Alzheimer's disease, autoimmune disease, and cancer."
          ]
        }
      },
      "career": {
        "title": "Investment History",
        "description": "SK Chemicals is seeking various strategic investment opportunities.",
        "fund": "Fund investment",
        "strategic": "Strategic investment"
      }
    }
  },

  "contactUs": {
    "p_title": "SK Chemicals always looks <br class='pc_only'/> for ways to make better pharmaceutical products",
    "t_c": {
      "title": "SK Chemicals Terms and Conditions",
      "li_title": {
        "1": "Personal Information",
        "2": "The purpose of collection and use of personal information",
        "3": "Period of possession and use of personal information"
      },
      "li_txt": {
        "1": "We collect your personal information for user sign up, customer consultations, and service requests. <ul><li>Personal information : email address, and contact information</li><li>Means of collection : our website (Ask a Question)</li><p></p></ul>",
        "2": "We use our customers' personal information for the purposes stated below. <ul><li>Management</li><li>To handle customer complaints and feedback</li><p></p></ul>",
        "3": "Your personal information will be destroyed without exception or delay after our customer support team achieves the purpose for which the information was collected and used."
      },
      "agree": "Agree",
      "submit": "Submit"
    },
    "info": {
      "address": "310 Pangyo-ro, Bundang-gu, Seongnam-si, Gyeonggi-do 463-400 Korea [13494]"
    }
  },

  "partnerships": {
    "p_title": "SK Chemicals always looks <br class='pc_only'/> for ways to make better pharmaceutical products",
    "text_board": {
      "1": {
        "title": "Overview",
        "description": "R&D is the source of competitiveness for pharmaceutical companies. As such, SK Chemicals has committed its research capabilities in developing pharmaceutical products with global competitiveness. SK Chemicals Research Center holds outstanding competencies and expertise across all stages of pharmaceutical R&D including drug formulations research, analytical research, process development and manufacturing of various dosage forms."
      },
      "2": {
        "title": "Quality by Design",
        "description": "R&D is the source of competitiveness for pharmaceutical companies. As such, SK Chemicals has committed its research capabilities in developing pharmaceutical products with global competitiveness. SK Chemicals Research Center holds outstanding competencies and expertise across all stages of pharmaceutical R&D including drug formulations research, analytical research, process development and manufacturing of various dosage forms."
      }
    },
    "partners": [
      {
        "name": "Standigm",
        "title": "Cure for rheumatoid arthritis",
        "description": "Discovery of rheumatoid arthritis treatment substances in the new drug re-creation approach and patent application",
        "searchLink": "https://www.google.com/search?q=sk%EC%BC%80%EB%AF%B8%EC%B9%BC+%EC%8A%A4%ED%83%A0%EB%8B%A4%EC%9E%84+%EB%A5%98%EB%A7%88%ED%8B%B0%EC%8A%A4+%EA%B4%80%EC%A0%88%EC%97%BC&tbm=nws"
      },
      {
        "name": "J2H Biotech",
        "title": "Joint research on the development of new drugs",
        "description": "Research on new drugs using Optiplex technology and Targeted Protein Degrader technology"
      },
      {
        "name": "Deargen",
        "title": "Joint research on drug re-creation",
        "description": "Signed a joint research agreement on drug repositioning and new drug development (De Novo Drug Design)"
      },
      {
        "name": "Dr. Noah Biotech",
        "title": "A joint study on artificial intelligence-based new drug development",
        "description": "Signed a joint research and development agreement on AI-based new drug development utilising 'ARK' platform technology"
      }
    ]
  }
}